IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

New Drug Shows Promise in Penetrating Pancreatic Cancer's 'Fibrotic Fortress'

Pancreatic cancer has an extremely low survival rate (97% mortality within 5 years for metastatic cases) due to late detection and the forma

麦科医药MT1002完成Ib/II期首例入组，卒中“双管线”布局加速推进

Combination therapy with RAS inhibitors shows promise for pancreatic cancer regression and resistance prevention

This research article presents a study on a targeted combination therapy for pancreatic ductal adenocarcinoma (PDAC), one of the deadliest c

Spanish Researchers Develop Breakthrough Therapy Protocol for Pancreatic Cancer Treatment

Spanish researchers have developed a new therapy protocol that could revolutionize pancreatic cancer treatment. Pancreatic cancer is notorio